St. Johns Investment Management Company, LLC Amgen Inc Transaction History

St. Johns Investment Management Company, LLC

  • $213 Million
  • Q3 2024

A detailed history of St. Johns Investment Management Company, LLC transactions in Amgen Inc stock. As of the latest transaction made, St. Johns Investment Management Company, LLC holds 5,488 shares of AMGN stock, worth $1.61 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
5,488
Previous 5,857 6.3%
Holding current value
$1.61 Million
Previous $1.83 Million 3.39%
% of portfolio
0.83%
Previous 0.87%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
SELL
$309.38 - $337.38 $114,161 - $124,493
-369 Reduced 6.3%
5,488 $1.77 Million
Q2 2024

Jul 25, 2024
SELL
$262.75 - $319.31 $57,805 - $70,248
-220 Reduced 3.62%
5,857 $1.83 Million
Q1 2024

Apr 15, 2024
BUY
$268.87 - $324.56 $118,033 - $142,481
439 Added 7.79%
6,077 $1.73 Million
Q4 2023

Feb 07, 2024
SELL
$255.7 - $288.46 $118,133 - $133,268
-462 Reduced 7.57%
5,638 $1.62 Million
Q3 2023

Oct 13, 2023
SELL
$218.65 - $271.46 $31,048 - $38,547
-142 Reduced 2.27%
6,100 $1.64 Million
Q2 2023

Jul 20, 2023
SELL
$214.27 - $253.37 $15,213 - $17,989
-71 Reduced 1.12%
6,242 $1.39 Million
Q1 2023

May 04, 2023
BUY
$225.79 - $275.2 $1,806 - $2,201
8 Added 0.13%
6,313 $1.53 Million
Q4 2022

Feb 10, 2023
SELL
$229.03 - $291.01 $13,512 - $17,169
-59 Reduced 0.93%
6,305 $1.66 Million
Q3 2022

Nov 02, 2022
BUY
$224.46 - $253.15 $19,303 - $21,770
86 Added 1.37%
6,364 $1.43 Million
Q2 2022

Aug 03, 2022
SELL
$230.71 - $256.74 $19,841 - $22,079
-86 Reduced 1.35%
6,278 $1.53 Million
Q1 2022

Apr 20, 2022
BUY
$219.27 - $242.57 $62,272 - $68,889
284 Added 4.67%
6,364 $1.54 Million
Q4 2021

Feb 08, 2022
SELL
$198.88 - $227.6 $9,347 - $10,697
-47 Reduced 0.77%
6,080 $1.37 Million
Q3 2021

Nov 04, 2021
SELL
$212.27 - $248.7 $46,062 - $53,967
-217 Reduced 3.42%
6,127 $1.3 Million
Q2 2021

Aug 04, 2021
SELL
$233.58 - $259.14 $18,219 - $20,212
-78 Reduced 1.21%
6,344 $1.55 Million
Q1 2021

Apr 30, 2021
BUY
$221.91 - $258.6 $10,207 - $11,895
46 Added 0.72%
6,422 $1.6 Million
Q4 2020

Feb 05, 2021
SELL
$216.38 - $257.67 $31,158 - $37,104
-144 Reduced 2.21%
6,376 $1.47 Million
Q3 2020

Oct 23, 2020
BUY
$234.65 - $260.95 $2,346 - $2,609
10 Added 0.15%
6,520 $1.66 Million
Q2 2020

Jul 27, 2020
SELL
$197.81 - $242.74 $41,144 - $50,489
-208 Reduced 3.1%
6,510 $1.54 Million
Q1 2020

Apr 27, 2020
SELL
$182.24 - $241.7 $3,827 - $5,075
-21 Reduced 0.31%
6,718 $1.36 Million
Q4 2019

Jan 30, 2020
SELL
$189.21 - $243.2 $20,245 - $26,022
-107 Reduced 1.56%
6,739 $1.63 Million
Q3 2019

Oct 21, 2019
SELL
$174.11 - $208.62 $15,147 - $18,149
-87 Reduced 1.25%
6,846 $1.33 Million
Q2 2019

Jul 24, 2019
SELL
$166.7 - $195.41 $7,334 - $8,598
-44 Reduced 0.63%
6,933 $1.28 Million
Q1 2019

Apr 17, 2019
SELL
$180.87 - $203.88 $21,342 - $24,057
-118 Reduced 1.66%
6,977 $1.33 Million
Q4 2018

Feb 05, 2019
SELL
$178.4 - $208.25 $34,788 - $40,608
-195 Reduced 2.67%
7,095 $1.38 Million
Q3 2018

Oct 22, 2018
SELL
$185.29 - $208.89 $92,830 - $104,653
-501 Reduced 6.43%
7,290 $1.51 Million
Q2 2018

Jul 18, 2018
SELL
$166.05 - $186.51 $11,125 - $12,496
-67 Reduced 0.85%
7,791 $1.44 Million
Q1 2018

May 03, 2018
SELL
$169.43 - $198.0 $169 - $198
-1 Reduced 0.01%
7,858 $1.34 Million
Q4 2017

Jan 16, 2018
SELL
$168.79 - $188.59 $67,516 - $75,436
-400 Reduced 4.84%
7,859 $1.37 Million
Q3 2017

Oct 17, 2017
BUY
$167.29 - $191.0 $1.38 Million - $1.58 Million
8,259
8,259 $1.54 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track St. Johns Investment Management Company, LLC Portfolio

Follow St. Johns Investment Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Johns Investment Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on St. Johns Investment Management Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email